FR2776511B1 - USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY - Google Patents

USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY

Info

Publication number
FR2776511B1
FR2776511B1 FR9803978A FR9803978A FR2776511B1 FR 2776511 B1 FR2776511 B1 FR 2776511B1 FR 9803978 A FR9803978 A FR 9803978A FR 9803978 A FR9803978 A FR 9803978A FR 2776511 B1 FR2776511 B1 FR 2776511B1
Authority
FR
France
Prior art keywords
inhibitor
preparation
composition
retinoic acid
acid activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9803978A
Other languages
French (fr)
Other versions
FR2776511A1 (en
Inventor
Jean Daniel Doutremepuich
Carole Marconnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9803978A priority Critical patent/FR2776511B1/en
Application filed by Galderma Research and Development SNC, Centre International de Recherches Dermatologiques Galderma filed Critical Galderma Research and Development SNC
Priority to BR9908411-2A priority patent/BR9908411A/en
Priority to KR1020007010470A priority patent/KR20010042104A/en
Priority to PCT/FR1999/000687 priority patent/WO1999049838A1/en
Priority to JP2000540805A priority patent/JP2002509870A/en
Priority to RU2000127111/14A priority patent/RU2193877C2/en
Priority to PL99343004A priority patent/PL343004A1/en
Priority to CN99804411A priority patent/CN1298290A/en
Priority to AU29388/99A priority patent/AU2938899A/en
Priority to IL13785999A priority patent/IL137859A0/en
Priority to CA002324899A priority patent/CA2324899A1/en
Priority to EP99910423A priority patent/EP1066017A1/en
Priority to HU0102411A priority patent/HUP0102411A3/en
Priority to ARP990101412A priority patent/AR015551A1/en
Publication of FR2776511A1 publication Critical patent/FR2776511A1/en
Priority to ZA200004483A priority patent/ZA200004483B/en
Priority to NO20004880A priority patent/NO20004880L/en
Application granted granted Critical
Publication of FR2776511B1 publication Critical patent/FR2776511B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9803978A 1998-03-31 1998-03-31 USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY Expired - Fee Related FR2776511B1 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (en) 1998-03-31 1998-03-31 USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY
CA002324899A CA2324899A1 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss
PCT/FR1999/000687 WO1999049838A1 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss
JP2000540805A JP2002509870A (en) 1998-03-31 1999-03-24 Use of Inhibitors of Retinoic Acid Activity to Delay Hair Loss
RU2000127111/14A RU2193877C2 (en) 1998-03-31 1999-03-24 Agent for changing hair growth in cosmetic or pharmaceutical composition, method for nontherapeutic treatment of hair and kit
PL99343004A PL343004A1 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss
CN99804411A CN1298290A (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss
AU29388/99A AU2938899A (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss
BR9908411-2A BR9908411A (en) 1998-03-31 1999-03-24 Use, in or for the preparation of a composition of at least one inhibitor of retinoic acid activity
KR1020007010470A KR20010042104A (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss
EP99910423A EP1066017A1 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss
HU0102411A HUP0102411A3 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss
IL13785999A IL137859A0 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss
ARP990101412A AR015551A1 (en) 1998-03-31 1999-03-30 USE OF AT LEAST ONE INHIBITOR OF THE ACTIVITY OF THE RETINOIC ACID, PRODUCTS THAT UNDERSTAND SUCH INHIBITOR AND PROCEDURES OF NOTERAPEUTIC TREATMENT TO DELAY OR PREVENT THE GROWTH OF THE HAIRS, OR TO DELAY THE FALL OF THE HAIRS / HAIRS /
ZA200004483A ZA200004483B (en) 1998-03-31 2000-08-29 Use of retinoic acid activity inhibitors to slow down hair loss.
NO20004880A NO20004880L (en) 1998-03-31 2000-09-28 Use of inhibitors of retinoic acid activity to reduce hair loss

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (en) 1998-03-31 1998-03-31 USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY

Publications (2)

Publication Number Publication Date
FR2776511A1 FR2776511A1 (en) 1999-10-01
FR2776511B1 true FR2776511B1 (en) 2001-05-11

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9803978A Expired - Fee Related FR2776511B1 (en) 1998-03-31 1998-03-31 USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY

Country Status (16)

Country Link
EP (1) EP1066017A1 (en)
JP (1) JP2002509870A (en)
KR (1) KR20010042104A (en)
CN (1) CN1298290A (en)
AR (1) AR015551A1 (en)
AU (1) AU2938899A (en)
BR (1) BR9908411A (en)
CA (1) CA2324899A1 (en)
FR (1) FR2776511B1 (en)
HU (1) HUP0102411A3 (en)
IL (1) IL137859A0 (en)
NO (1) NO20004880L (en)
PL (1) PL343004A1 (en)
RU (1) RU2193877C2 (en)
WO (1) WO1999049838A1 (en)
ZA (1) ZA200004483B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (en) * 1995-05-03 1997-05-30 Cird Galderma USE OF RETINOIDS IN A COSMETIC COMPOSITION OR FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION
FR2739777B1 (en) * 1995-10-11 1997-11-14 Cird Galderma LIGAND ANTAGONIST RAR-GAMMA OR AGONIST RAR-ALPHA AS AN APOPTOSIS INHIBITOR
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
HUP9902645A3 (en) * 1996-03-18 1999-12-28 Eisai Co Ltd Fused-ring carboxylic acid derivatives

Also Published As

Publication number Publication date
BR9908411A (en) 2000-12-05
AR015551A1 (en) 2001-05-02
HUP0102411A3 (en) 2002-12-28
CA2324899A1 (en) 1999-10-07
JP2002509870A (en) 2002-04-02
AU2938899A (en) 1999-10-18
IL137859A0 (en) 2001-10-31
KR20010042104A (en) 2001-05-25
CN1298290A (en) 2001-06-06
FR2776511A1 (en) 1999-10-01
ZA200004483B (en) 2002-02-27
WO1999049838A1 (en) 1999-10-07
NO20004880D0 (en) 2000-09-28
HUP0102411A2 (en) 2001-11-28
RU2193877C2 (en) 2002-12-10
PL343004A1 (en) 2001-07-30
EP1066017A1 (en) 2001-01-10
NO20004880L (en) 2000-11-30

Similar Documents

Publication Publication Date Title
FR2772609B1 (en) USE OF AT LEAST ONE AUXIN IN A COSMETIC COMPOSITION
FR2733684B1 (en) USE OF RETINOIDS IN A COSMETIC COMPOSITION OR FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION
FR2732594B1 (en) USE OF DERIVATIVES OF SALICYLIC ACID FOR DEPIGMENTATION OF THE SKIN
FR2753058B1 (en) LIQUID OR SEMI-LIQUID APPLICATION ASSEMBLY
FR2764176B1 (en) ARTICULATION FOR CHILDREN'S PARK
FR2759292B1 (en) USE OF RETINOIDS AS PIGMENTATION INDUCING AGENTS
DE69731674D1 (en) Silencieux d'aspiration pour compresseur
FR2773069B1 (en) COSMETIC COMPOSITION COMPRISING AT LEAST ONE AMIDOETHERCARBOXYLIC ACID SURFACTANT AND AT LEAST ONE ASSOCIATION OF AN ANIONIC POLYMER AND A CATIONIC POLYMER
MA24391A1 (en) PROGESTERONE TO TREAT OR REDUCE ISCHEMIA
FR2738746B1 (en) USE OF AT LEAST ONE PEPTIDE IN A COSMETIC COMPOSITION OR FOR THE PREPARATION OF A MEDICAMENT
CA2255229A1 (en) Use of cinnamic acid, or of its derivatives, as a firming agent in a cosmetic composition
FR2740333B1 (en) USE OF A SUBSTANCE P ANTAGONIST IN A TOPICAL COMPOSITION AS AN ANTITRANSPIRANT AGENT
ITMI991545A0 (en) JOINT FOR IMPROVED BRAKING STABILITY AND LOWER DEFORMATION DUE TO EXCESSIVE TIGHTENING
FR2752596B1 (en) OPTIMAL TORQUE OF MATERIALS FOR FRONTAL METAL SEALING IN BOREHOLE DRILLS
FR2756025B1 (en) CARDAN STRUCTURE FOR THE ARTICULATED CONNECTION OF A HEXAPODE
FR2753627B1 (en) USE OF INHIBITORS OF RETINOIC ACID ACTIVITY TO PROMOTE HEALING
FR2676362B3 (en) PROCESS FOR INCREASING THE ACTIVITY OF AT LEAST ONE ACTIVE IN A COMPOSITION FOR COSMETIC AND / OR DERMOPHARMACEUTICAL USE AND COMPOSITION FOR CARRYING OUT SAID METHOD.
FR2772610B1 (en) USE OF CINNAMIC ACID OR AT LEAST ONE OF ITS DERIVATIVES IN A COSMETIC COMPOSITION
FR2750045B1 (en) USE OF COLLOIDAL SILICIC ACID IN A NAIL VARNISH COMPOSITION
FR2778560B1 (en) USE OF CINNAMIC ACID OR AT LEAST ONE OF ITS DERIVATIVES IN A COMPOSITION FOR PROMOTING DEQUAMATION OF THE SKIN, AND COMPOSITION COMPRISING SAME
FR2776511B1 (en) USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY
FR2770841B1 (en) CONCENTRATED HYDROALCOHOLIC FLUID ALKYLAMIDOPROPYLBETAN COMPOSITIONS OF COPRAH OR PALMIST
MA25184A1 (en) PRODUCTION OF ACID FOR FOOD.
FR2769838B1 (en) USE OF NITROGEN DERIVATIVES FOR THE PREPARATION OF A DERMATOLOGICAL OR COSMETOLOGICAL COMPOSITION
FR2771008B1 (en) USE OF KETOLIDES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR PREVENTING ARTERIAL THROMBOTIC COMPLICATIONS LINKED TO ATHEROSCLEROSIS

Legal Events

Date Code Title Description
ST Notification of lapse